Navigation Links
NewCardio Announces Positive Results From Third Clinical Validation Study
Date:8/13/2008

so anticipate developing an interface to discuss these important and compelling clinical validation data with drug regulators. We will soon augment our senior management team in an effort to add sales and marketing leadership to accelerate the commercialization initiative."

About QTinno(TM)

QTinno(TM) is a software suite that provides automated, comprehensive analysis of QT intervals and other ECG-based cardiac safety for the pharmaceutical industry and drug regulators. Its key features include full automation with minimal to no human intervention required, greatly improving the productivity, accuracy and precision of clinical trials. NewCardio believes QTinno(TM) is equal to the best manual assessments and is able to provide high-quality quantitative data from a broad range of difficult-to-read ECGs.

About NewCardio, Inc.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit http://www.newcardio.com.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. T
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
2. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
3. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
4. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
5. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
6. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
7. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
8. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
9. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
10. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
11. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage ... regeneration, today announced that J.J. Finkelstein , chief ... corporate overview at two upcoming investor conferences. ... th Annual Microcap Conference on Thursday May 28, ... at 11:00 am EDT.  A webcast will be available ...
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... of the results of the Company,s 72-patient, placebo-controlled ... drops) for the treatment of dry eye patients ... ) model.  The exploratory study was completed in ... disseminated by the Company in a press release, ...
(Date:5/22/2015)... May 20, 2015 Research and Markets( ... "Guide to Prepare Application Dossiers for Oversea ... Edition) " report to their offering. ... of segment market of the most growth potentiality, ... device manufacturers and producers to penetrate such market. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
... Device Designed for Type-2 Diabetes Patients Who Are Overweight ... to Current Oral Anti-Diabetic Treatments Device ... NEW YORK, March 28 New York-Presbyterian Hospital/Weill,Cornell Medical ... of an investigational implantable device designed to help,those with ...
... Preclinical Data Indicates MSI-1436 Does Not Alter Rate of Dopamine ... ... 28 Genaera,Corporation (Nasdaq: GENR ) announced that preclinical data was ... Roitman, Ph.D., a Genaera collaborator and investigator with the,University of Illinois at ...
Cached Medicine Technology:New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients 2Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting 2Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting 3Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting 4
(Date:5/22/2015)... May 22, 2015 Memorial Day weekend is ... Insurance is offering some tips to help promote safe ... there will be 383 traffic fatalities this Memorial Day weekend. ... National Highway Traffic Safety Association: , , ... vehicle is wearing a seatbelt, whether they’re driving or riding ...
(Date:5/22/2015)... MOUNTAIN VIEW, California (PRWEB) May 22, 2015 ... Breakers, has set a RecordSetter.com World Record at the 104th ... Coco Libre coconut water ice luge served 315 people in ... Zappos.com Bay to Breakers race is so true to the ... that we felt bringing an ice luge to the finish ...
(Date:5/22/2015)... 22, 2015 The dentist ... announces that they are now offering complimentary consultations ... dental treatments. At consultations, patients can discuss their ... what certain treatments can achieve and whether alternative ... this initial appointment. If treatments are chosen, patients ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the ... now the 16th sweetFrog store located in the Lone Star ... on the Inc. 500 list of fastest growing companies in ... East Texas for 20 years and love the natural beauty ... and nearby Palestine, sweetFrog locations. “We are really excited about ...
(Date:5/22/2015)... May 22, 2015 DMG Productions announces ... scheduled to broadcast on Friday, May 29, 2015 at ... Channel. , In this episode Innovations will explore Interstate ... to business quickly through disaster recovery and restoration. , ... that works collaboratively to develop and deliver training and ...
Breaking Medicine News(10 mins):Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2
... GORDONSVILLE, Va., May 28 PBM Holdings, Inc., ... announced today that,its Chinese affiliate company, PBM (Guangzhou) ... of the China earthquake. PBM is,partnering with the ... Red,Cross, an affiliate of the Red Cross Society ...
... in helping ... and stay on therapy, DENVER, May 28 Nearly all ... their commitment to,managing their disease in every way possible is their ... survey of people with,MS, results of which were released today at ...
... Study estimates savings of more than $60 million over 11 ... use of air bags and seat belts significantly reduces injuries ... crash and also lowers in-hospital death rates, injury severity and ... , It also suggests that optimal use of air bags ...
... published in the May 2008 (volume 8, issue 25) ... (pic-noj-en-all), an antioxidant plant extract from the bark of ... type II diabetes patients, allows people to lower ... factors. The study, conducted at the University of Arizona, ...
... The old,saying, "beauty is in the eye ... study in a recent issue of Plastic and ... Society of Plastic,Surgeons (ASPS), found that variations in ... your facial expressions, and,subsequent mood, are perceived by ...
... China Sky One,Medical, Inc. (Amex: CSY ) ... and distributor of pharmaceutical, medicinal and,diagnostic products in ... Public Accountants and Advisors LLP (,Moore Stephens,) as ... terminated its,contract with Sherb & Co., LLP that ...
Cached Medicine News:Health News:PBM Companies Partner with the Red Cross to Donate Infant Formula to China Earthquake Victims 2Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 2Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 3Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 4Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 5Health News:Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals 6Health News:Air Bags-Seat Belts Cut Injuries, Deaths, Costs 2Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 2Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 3Health News:Looking Tired or Angry May Have More to do With Facial Aesthetics Than How You Feel, ASPS Study Reveals 2Health News:Looking Tired or Angry May Have More to do With Facial Aesthetics Than How You Feel, ASPS Study Reveals 3Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 2Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 3
Provides a combination of concentrated cold / hot and compression for the knee...
Provides a combination of concentrated cold / hot and compression for the wrist...
Provides compression, support, immobilization for the knee in addition to cold / hot therapy...
... One-Piece™ Collar is completely injected molded from ... our patented chin support. , ,Our ... efficiently managed where space is limited. Color-coded ... of sizes., ,Either in a supine ...
Medicine Products: